MCID: PTN001
MIFTS: 48

Patent Foramen Ovale malady

Rare diseases, Cardiovascular diseases, Fetal diseases categories

Aliases & Classifications for Patent Foramen Ovale

About this section
Sources:
10Disease Ontology, 45NIH Rare Diseases, 47Novoseek, 12DISEASES, 51Orphanet, 65UMLS, 36MeSH, 59SNOMED-CT, 42NCIt, 28ICD10 via Orphanet, 37MESH via Orphanet, 66UMLS via Orphanet
See all sources

Aliases & Descriptions for Patent Foramen Ovale:

Name: Patent Foramen Ovale 10 12 51
Atrial Septal Defect Within Oval Fossa 10 65
Foramen Ovale, Patent 65 36
Foramen Ovale Patent 10 47
Atrial Septal Defect, Ostium Secundum Type 51
Ostium Secundum Type Atrial Septal Defect 10
Atrial Septal Defect Ostium Secundum 45
 
Persistent, Ostium Secundum 10
Persistent Ostium Secundum 10
Asd, Ostium Secundum Type 51
Asd Ostium Secundum Type 45
Ostium Secundum Asd 45
Defect, Patent 10


Classifications:



External Ids:

Disease Ontology10 DOID:13620
MeSH36 D054092
NCIt42 C34619
Orphanet51 99108, 99103
ICD10 via Orphanet28 Q21.1
MESH via Orphanet37 D054092
UMLS via Orphanet66 C0016522, C0344724

Summaries for Patent Foramen Ovale

About this section
MalaCards based summary: Patent Foramen Ovale, also known as atrial septal defect within oval fossa, is related to stroke, ischemic and retinitis. An important gene associated with Patent Foramen Ovale is NKX2-5 (NK2 Homeobox 5), and among its related pathways are HOP Signaling and Heart Development. Affiliated tissues include brain, heart and liver, and related mouse phenotypes are muscle and skeleton.

Related Diseases for Patent Foramen Ovale

About this section

Diseases related to Patent Foramen Ovale via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 295)
idRelated DiseaseScoreTop Affiliating Genes
1stroke, ischemic31.4APOH, F2, F5, FGA, MTHFR, SERPINC1
2retinitis31.4APOH, F2, F5, MTHFR, SERPINC1
3myocardial infarction31.2F13A1, F2, F5, FGA, GATA4, MTHFR
4thrombophilia due to thrombin defect31.0APOH, F13A1, F2, F5, MTHFR, SERPINC1
5endocardium disease30.8APOH, F2, F5, SERPINC1
6budd-chiari syndrome30.8APOH, F2, F5, MTHFR, SERPINC1
7holt-oram syndrome30.4MYH6, NKX2-5, TBX5
8aneurysm11.2
9atrial septal aneurysm11.2
10pulmonary embolism11.0
11congenital heart disease11.0
12atrial heart septal defect11.0
13heart septal defect11.0
14congenital heart disease, atrial septal defect11.0
15cerebritis10.9
16headache10.9
17ischemia10.9
18vascular malformation10.8
19atrial septal defect 210.8
20congenital nervous system abnormality10.8
21migraine with aura10.8
22sleep apnea10.8
23obstructive sleep apnea10.8
24atrial septal defect 110.7
25atrial septal defect 310.7
26coronary heart disease 310.7
27cerebrovascular disease10.7
28atrial septal defect 610.7
29coronary heart disease 610.7
30pulmonary hypertension10.7
31brain ischemia10.7
32retinal artery occlusion10.7
33transient cerebral ischemia10.7
34congenital cardiovascular shunt10.7
35migraine with or without aura 110.6
36atrial septal defect 410.6
37coronary thrombosis10.6
38atrial fibrillation10.6
39endocarditis10.6
40acute respiratory distress syndrome10.6
41greenberg skeletal dysplasia10.5
42coronary heart disease 410.5
43peripheral vascular disease10.5
44acute cor pulmonale10.5
45coronary aneurysm10.5
46blood platelet disease10.5
47heart aneurysm10.5
48thrombophilia10.5
49neurologic diseases10.5
50coronary arteries congenital malformation10.5

Graphical network of the top 20 diseases related to Patent Foramen Ovale:



Diseases related to patent foramen ovale

Symptoms for Patent Foramen Ovale

About this section

Drugs & Therapeutics for Patent Foramen Ovale

About this section

Drugs for Patent Foramen Ovale (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 20)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
AspirinapprovedPhase 4, Phase 3, Phase 297150-78-22244
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(ACETYLOXY)benzoic acid
2-(Acetyloxy)benzoate
2-(Acetyloxy)benzoic acid
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
2349-94-2
26914-13-6
50-78-2
7 Select Adult Chewable Aspirin
7 Select Aspirin
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. Empirin
A.S.A. empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
ACETYLSALICYLIC ACID
AI3-02956
AIN
AKOS000118884
ASA
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acide 2-(acetyloxy)benzoique
Acide acetylsalicylique
Acide acétylsalicylique
Acido O-acetil-benzoico
Acido acetilsalicilico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
Adult Chewable Low Dose Aspirin
Adult Low Dose Aspirin
Adult Low Dose Aspirin Enteric Safety Coated
Adult Low Dose Enteric Coated Aspirin
Adult Low Strength Aspirin
Aloxiprimum
Asacard
Asagran
Asaphen
Asatard
Ascoden-30
Ascriptin Maximum Strength Buffered Aspirin
Ascriptin Regular Strength Buffered Aspirin
Aspalon
Aspec
Aspergum
Aspi-cor
Aspir Low
Aspir-Mox
Aspirdrops
Aspirin
Aspirin (JP15/USP)
Aspirin 81 Mg
Aspirin 81 Mg Low Dose
Aspirin Adult Low Dose
Aspirin Adult Low Strength
Aspirin Adult Low Strength Aspirin
Aspirin Adult low strength
Aspirin Chewable Low Dose
Aspirin Delayed Release
Aspirin EC
Aspirin EXTRA STRENGTH
Aspirin Ec
Aspirin Enteric
Aspirin Enteric Coated
Aspirin Enteric Coated Low Dose
Aspirin Enteric Safety Coated
Aspirin Enteric Safety-Coated
Aspirin Low Dose
Aspirin Low Dose Chewable
Aspirin Low Dose Enteric Coated
Aspirin Low Dose Safety Coated
Aspirin Low Strength
Aspirin Nsaid
Aspirin Regular Strength
Aspirin Regular Strength regular strength
Aspirin Regular strength
Aspirin Safety Coated
Aspirin Safety Coated Adult Low Dose
Aspirin Safety coated
Aspirin Thin coated
Aspirin [BAN:JAN]
Aspirin adult low dose
Aspirin adult low strength
Aspirin enteric safety coated
Aspirin low dose
Aspirin low dose chewable
Aspirin low dose enteric coated
Aspirin regular strength
Aspirina 03
Aspirine
Aspiring
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
BIDD:GT0118
BRN 0779271
Bay-e-4465
Bayer
Bayer Advanced Aspirin Extra Strength
Bayer Advanced Aspirin Regular Strength
Bayer Aspirin 8 Hour
Bayer Aspirin Regimen Chewable Low Dose Aspirin Orange
Bayer Aspirin Regimen Regular Strength
Bayer Buffered
Bayer Chewable - Aspirin Regimen Low Dose Aspirin Cherry Flavored
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Fast Release
Bayer Genuine Aspirin
Bayer Low Dose
Bayer Plus
Bayer Plus Extra Strength
Bayer Womens
Benaspir
Bi-prin
Bialpirina
Bialpirinia
Buffered Aspirin
Bufferin
Bufferin LOW DOSE BUFFERED ASPIRIN
C01405
CCRIS 3243
CHEBI:15365
CHEMBL25
CID2244
Caprin
Cardioaspirin
Cardioaspirina
Care One Aspirin
Cemirit
Chewable Adult Low Dose Aspirin
Chewable Aspirin
Chewable Low Dose Aspirin
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Critical Care Aspirin To Go
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dg Health Aspirin
Direct Safety Aspirin
Dispril
DivK1c_000555
Dolean pH 8
Duramax
ECM
EINECS 200-064-1
EU-0100038
Easprin
Easprin (TN)
Ec-81aspirin Enteric Coated
Ecolen
Ecotrin
Ecotrin Regular Strength
Empirin
Empirin with Codeine
Endosprin
Endydol
Enteric Aspirin
Enteric Coated Aspirin
Enteric Coated Aspirin Regular Strength
Enteric Coated Aspirin Regular strength
Enteric Coated Aspirin regular strength
Enteric Coated Asprin 81 Mg
Enteric Coated Low Dose Aspirin
 
Enteric Safety Coated Aspirin
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
Equaline Aspirin
Equaline Aspirin adult low dose
Equate Aspirin
Equate Aspirin chewable
Extren
Fasprin
Flanax Aspirin Pain Reliever
Formucare Aspirin
Genuine Aspirin
Globentyl
Globoid
Good Neighbor Pharmacy Aspirin
Good Neighbor Pharmacy Aspirin Enteric Safety Coated
Good Neighbor Pharmacy Aspirin orange flavor chewable
Good Sense Aspirin
Good Sense Aspirin Enteric Safety Coated
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
Handy Solutions Genuine Aspirin Bayer
Health Mart Aspirin
Health Mart Regular Strength Enteric Coated Aspirin
Health Sense Adult Chewable Low Strength Aspirin
Health Sense Aspirin 81
Health Sense Ecpirin
Healthy Accents Aspirin
Helicon
Henry Schein Aspirin
I14-7505
IDI1_000555
Idragin
Istopirin
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kapsazal
Kroger Value Aspirin
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LS-143
Leader Aspirin
Leader Cardinal Health Aspirin
Leader Low Dose Aspirin
Levius
Lopac-A-5376
Lopac0_000038
Low Dose Adult Aspirin
Low Dose Aspirin
Low Dose Aspirin 81 Mg Safety Coated
Low Dose Aspirin Enteric Safety Coated
Low Dose Asprin
Low Dose Chewable Aspirin
Low Dose Miniprin Enteric Safety Coated
Low Dose Pain Relief Aspirin
Low Strength Chewable Aspirin
Low-dose Aspirin
MLS001055329
MLS001066332
MLS001336045
MLS001336046
Magnecyl
Measurin
Medi First Plus Aspirin
Medi-first Aspirin
Medique Aspirin
Medisyl
Micristin
Micro-coated Aspirin
Miniprin
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
NCI60_002222
NINDS_000555
NSC 27223
NSC27223
NSC406186
Neuronika
North Aspirin
Novasen
Novid
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-Acetoxybenzoate
O-Acetoxybenzoic acid
O-Acetylsalicylic acid
O-Carboxyphenyl acetate
O-accetylsalicylic acid
O-acetylsalicylic acid
PL-2200
Pain Relief Aspirin
Pain Relief Aspirin Low Dose
Persistin
Pharbest Aspirin 325mg
Pharbest Regular Strength Aspirin
Pharmacin
Pirseal
Plus Pharma NSAID 325 mg
Plus Pharma Nsaid Aspirin
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rapid Comfort Aspirin
Regular Strength Aspirin
Regular Strength Aspirin Ec
Regular Strength Buffered Aspirin
Regular Strength Enteric Aspirin
Regular Strength Enteric Coated Aspirin
Regular Strength Pain Relief
Regular Strength Tri-buffered Aspirin
Rexall Aspirin
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
Rugby Aspirin
Rx Act Aspirin
S-211
SMR000059138
SP 189
SPBio_001838
SPECTRUM1500130
ST075414
Safety Coated Aspirin
Safety Coated Enteric Aspirin
Salacetin
Salcetogen
Saletin
Salicylic acid acetate
Salicylic acid, acetate
Salospir
Smart Health Aspirin regular strength
Smart Sense Aspirin
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
Solves - Aspirin Cherry
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spectrum_001245
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
St. Joseph Chewable Aspirin
St. Joseph Safety Coated Aspirin
Sunmark Aspirin
Sunmark Aspirin Regular Strength
Sunmark Aspirin adult low strength
Sunmark Aspirin low dose
Supac
Tasprin
Temperal
Toldex
Topcare Aspirin
Tri-buffered Aspirin
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII-R16CO5Y76E
UNII=R16CO5Y76E
UNM-0000306102
Uncoated Aspirin
Value Pharma Aspirin Pain Reliever
Value Pharmapain Reliever Extra Strength
Vanquish
WLN: QVR BOV1
XAXA
Xaxa
Yasta
ZORprin
Zee Aspirin
aspirin
cMAP_000006
component of Midol
component of Synirin
nchem.859-comp6
o-Acetoxybenzoic acid
o-Carboxyphenyl acetate
o-acetoxybenzoic acid
o-carboxyphenyl acetate
ácido acetilsalicílico
2
WarfarinapprovedPhase 4, Phase 2, Phase 339181-81-26691, 54678486
Synonyms:
(-)-Warfarin
(S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone
(S)-Warfarin
(phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarin
(phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarine
1-(4'-Hydroxy-3'-coumarinyl)-1-phenyl-3-butanone
200 Coumarin
200 coumarin
3-(1'-Phenyl-2'-acetylethyl)-4-hydroxycoumarin
3-(Acetonylbenzyl)-4-hydroxycoumarin
3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin
3-(alpha-Phenyl-beta-acetylaethyl)-4-hydroxycumarin
3-(alpha-Phenyl-beta-acetylethyl)-4-hydroxycoumarin
4-Hydroxy-3- (3-oxo-1-fenyl-butyl) cumarine
4-Hydroxy-3- (3-oxo-1-phenyl-butyl)-cumarin
4-Hydroxy-3-(3-oxo-1-fenyl-butyl) cumarine
4-Hydroxy-3-(3-oxo-1-phenyl-butyl)-cumarin
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin
4-Idrossi-3- (3-oxo-)-fenil-butil)-cumarine
4-Idrossi-3-(3-oxo-)-fenil-butil)-cumarine
4-Idrossi-3-(3-oxo-1-fenil-butil)-cumarine
45706_FLUKA
45706_RIEDEL
4oh-coumarin deriv.
5543-56-6
5543-57-7
81-81-2
A2250_FLUKA
A2250_SIGMA
AC-15978
AC1L1N37
AC1Q6AN3
AR-1E2310
Arab Rat Death
Arab rat death
Arab rat deth
Athrombin
Athrombin-K
Athrombin-k
Athrombine-K
Athrombine-k
BRD-A24514565-001-02-2
BRD-A24514565-236-01-6
BRN 1293536
BSPBio_002026
Bio-0586
Brumolin
C01541
C19H16O4
CBDivE_002127
CBDivE_013236
CBKinase1_000192
CBKinase1_012592
CHEBI:10033
CHEMBL1464
CID6691
CO-Rax
Caswell No. 903
Choice
Choice (TN)
Co-Rax
Co-rax
Compound 42
Coumadin
Coumadin Tabs
Coumafen
Coumafene
Coumafene [French]
Coumaphen
Coumaphene
Coumarins
Coumefene
Cov-R-Tox
Cov-R-tox
D-Con
D08682
DB00682
DL-3-(alpha-acetonylbenzyl)-4-hydroxycoumarin
Dethmor
Dethnel
Dicusat E
Dicusat e
DivK1c_000444
EINECS 201-377-6
EINECS 226-907-3
EPA Pesticide Chemical Code 086002
Eastern states duocide
Fasco fascrat powder
Frass-Ratron
Frass-ratron
HMS1921K07
HMS2092C20
HMS501G06
HSDB 1786
I14-0958
IDI1_000444
Jantoven
KBio1_000444
KBio2_000674
KBio2_003242
KBio2_005810
KBio3_001526
KBioGR_000901
KBioSS_000674
Killgerm sewarin p
Kumader
Kumadu
Kumatox
Kypfarin
LS-55083
Latka 42
Latka 42 [Czech]
Liqua-tox
MLS001304042
Maag Rattentod Cum
Maag rattentod cum
Mar-Frin
Mar-frin
Marevan
Martin'S mar-frin
Martin's mar-frin
 
Maveran
MolPort-001-787-822
Mouse pak
NCGC00094810-01
NCGC00094810-02
NCGC00159398-03
NCGC00178855-01
NINDS_000444
NSC 59813
NSC59813
PS104_SUPELCO
Panwarfin
Place-Pax
Place-pax
Prothromadin
RAX
RCR grey squirrel killer concentrate
RCRA waste no. P001
Rat & mice bait
Rat and mice bait
Rat-B-gon
Rat-Gard
Rat-Kill
Rat-Mix
Rat-O-cide #2
Rat-O-cide no. 2
Rat-Ola
Rat-Trol
Rat-a-way
Rat-alpha-way
Rat-b-gon
Rat-beta-gon
Rat-gard
Rat-kill
Rat-mix
Rat-o-cide #2
Rat-ola
Rat-trol
Ratorex
Ratox
Ratoxin
Ratron
Ratron G
Ratron g
Rats-no-more
Ratten-Koederrohr
Ratten-koederrohr
Rattenstreupulver Neu Schacht
Rattenstreupulver neu schacht
Rattenstreupulver new schacht
Rattentraenke
Rattunal
Rcra waste number P001
Ro-Deth
Ro-deth
Rodafarin
Rodafarin C
Rodafarin c
Rodex
Rodex blox
Rosex
Rough & ready mouse mix
Rough and ready mouse mix
SMP1_000316
SMR000718754
SPBio_000870
SPECTRUM1500613
STK364490
Sakarat
Sewarin
Sofarin
Solfarin
Sorexa Plus
Sorexa plus
Spectrum2_000935
Spectrum3_000583
Spectrum4_000381
Spectrum5_001751
Spectrum_000194
Spray-trol brand roden-trol
Temus W
Temus w
Tintorane
Tox-Hid
Tox-hid
Twin light rat away
UNII-5Q7ZVV76EI
Vampirinip II
Vampirinip III
Vampirinip iii
W.A.R.F. 42
WARF compound 42
WLN: T66 BOVJ DYR&1V1 EQ
Waran
Warf 10
Warf 42
Warfarat
Warfarin (INN)
Warfarin (and salts of)
Warfarin Plus
Warfarin Q
Warfarin Sodium
Warfarin [BSI:ISO]
Warfarin [INN:BAN]
Warfarin plus
Warfarin plus [discontinued]
Warfarin sodium
Warfarin titrated to an INR of 2.5-3.0
Warfarin(R)
Warfarina
Warfarina [INN-Spanish]
Warfarine
Warfarine [INN-French]
Warfarine [ISO-French]
Warfarinum
Warfarinum [INN-Latin]
Warficide
Warfilone
Zoocoumarin
Zoocoumarin [Netherlands and USSR]
Zoocoumarin [Russian]
delta-Con
nchembio.307-comp19
rac-Warfarin
warfarin
3
Clopidogrelapproved, nutraceuticalPhase 4, Phase 3, Phase 2674120202-66-6, 113665-84-260606
Synonyms:
( )-(S)-Clopidogrel
(+)-(S)-Clopidogrel
(+)-Clopidogrel
(S)-Clopidogrel
(S)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate
113665-84-2
AC-19024
AC1L1TKZ
AC1Q41I9
BIDD:GT0284
BRD-K27721098-065-02-9
BSPBio_003211
C16H16ClNO2S
CGE
CHEBI:37941
CHEMBL1771
CID60606
CLOPIDOGREL SULFATE
CPD000550475
Clopidogrel
Clopidogrel (INN)
Clopidogrel (TN)
Clopidogrel Bisulfate
Clopidogrel [BAN:INN]
Clopidogrel [Ban:Inn]
Clopidogrel [INN:BAN]
Clopidogrel bisulfate
Clopidogrel bisulphate
Clopidogrel sulfate
Clopidogrelum
D07729
DB00758
DivK1c_000787
HMS2090O21
HMS502H09
HSDB 7430
 
IDI1_000787
Isocover
KBio1_000787
KBio2_000545
KBio2_003113
KBio2_005681
KBio3_002431
KBioGR_000689
KBioSS_000545
LS-172232
MLS001165708
MLS001195633
MLS001304711
Methyl (+)-(S)-alpha-(o-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4H)-acetate
MolPort-002-885-817
MolPort-003-845-991
NCGC00163329-02
NINDS_000787
Plavix
Plavix (TN)
SAM002589956
SMR000550475
SPBio_000463
SR 25990
STK580572
STOCK5S-27782
Spectrum2_000512
Spectrum3_001606
Spectrum4_000175
Spectrum_000105
TL8000400
UNII-A74586SNO7
Zyllt
clopidogrel
clopidogrel, (+)(S)-isomer
methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate
methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate
nchem.651-comp8
4
DipyridamoleapprovedPhase 3, Phase 27558-32-23108
Synonyms:
2,6-Bis(diethanolamine)-4,8-dipiperidinopyrimido[5,4-d]pyrimidine
2,6-Bis(diethanolamino)-4,8-dipiperidinopyrimido(5,4-d)pyrimidine
2,6-Bis(diethanolamino)-4,8-dipiperidinopyrimido[5,4-d]pyrimidine
4-26-00-03840 (Beilstein Handbook Reference)
58-32-2
AB00051974
AC-18100
AC1L1F6T
AC1Q7CXU
AC1Q7CXW
AC1Q7CXX
AKOS000509426
Agilease
Anginal
Antistenocardin
Apo-Dipyridamole
Apo-Dipyridamole Fc
Apo-Dipyridamole Sc
Apotex Brand of Dipyridamole
Apricor
Ashbourne Brand of Dipyridamole
BAS 00818792
BIM-0050449.0001
BPBio1_000270
BRD-K86301799-001-04-1
BRN 0068373
BSPBio_000244
BSPBio_001554
BSPBio_001924
Belmac Brand of Dipyridamole
Berlin Chemie Brand of Dipyridamole
Berlin-Chemie Brand of Dipyridamole
Bio-0173
Boehringer Ingelheim Brand of Dipyridamole
C24H40N8O4
CAS-58-32-2
CHEBI:4653
CHEMBL932
CID3108
CPD000058382
Cardioflux
Cardoxil
Cardoxin
Cerebrovase
Chilcolan
Cleridium
Cleridium 150
Coribon
Coridil
Coronarine
Corosan
Coroxin
Curantil
Curantyl
D 9766
D00302
D004176
D2274
D9766_SIGMA
DB00975
Dipiridamol
Dipiridamol [INN-Spanish]
Dipyramidole
Dipyridamine
Dipyridamol
Dipyridamole
Dipyridamole (JP15/USP/INN)
Dipyridamole [USAN:INN:BAN:JAN]
Dipyridamolum
Dipyridamolum [INN-Latin]
Dipyridan
Dipyudamine
DivK1c_000696
Dypyridamol
EINECS 200-374-7
EU-0100464
Gulliostin
HMS1568M06
HMS1791N16
HMS1920I10
HMS1989N16
HMS2089N15
HMS2091O18
 
HMS502C18
IDI1_000696
IPRAD Brand of Dipyridamole
Iv Persantine
Justpertin
KBio1_000696
KBio2_001484
KBio2_004052
KBio2_006620
KBio3_001144
KBioGR_001123
KBioSS_001484
Kurantil
LS-66732
Lopac-D-9766
Lopac0_000464
MLS000028420
MLS001076306
MLS001333724
Miosen
MolPort-001-792-504
NCGC00015385-01
NCGC00015385-02
NCGC00015385-03
NCGC00015385-07
NCGC00015385-15
NCGC00023914-02
NCGC00023914-04
NCGC00023914-05
NCGC00023914-06
NCGC00023914-07
NCGC00023914-08
NCGC00023914-09
NCGC00023914-10
NCGC00023914-11
NCI60_005689
NINDS_000696
NSC 515776
NSC-515776
NSC515776
Natyl
Novo-Dipiradol
Novopharm Brand of Dipyridamole
Peridamol
Permiltin
Permole, Persantine, Dipyridan, Dipyridamole
Persantin
Persantine
Persantine (TN)
Piroan
Prandiol
Prandiol 75
Prestwick0_000142
Prestwick1_000142
Prestwick2_000142
Prestwick3_000142
Prestwick_145
Protangix
RA 8
RA-8
S1867_Selleck
S1895_Selleck
SAM002264609
SMP2_000208
SMR000058382
SPBio_001003
SPBio_002183
SPECTRUM1500259
Spectrum2_000972
Spectrum3_000402
Spectrum4_000522
Spectrum5_000839
Spectrum_001004
Stenocardil
Stenocardiol
Stimolcardio
Tocris-0691
UNII-64ALC7F90C
UPCMLD-DP072
UPCMLD-DP072:001
Usaf Ge-12
WLN: T66 BN DN GN INJ CCN HCN E- AT6NTJ B2Q F2Q& J- AT6NTJ B2Q F2Q
ZINC00643046
dipyridamole
5
RivaroxabanapprovedPhase 3190366789-02-8
Synonyms:
BAY 59-7939
 
BAY59-7939
Xarelto
6Antithrombin IIIPhase 3259
7Antivitamins KPhase 38
8AntithrombinsPhase 3268
9DabigatranPhase 3182
10Aspirin, dipyridamole drug combinationPhase 325
11serineNutraceuticalPhase 3420
12
PolidocanolapprovedPhase 2219002-92-0
Synonyms:
2-Hydroxyethyl lauryl ether
Asclera
Dodecylpolyethyleneglycolether
Ethylene glycol mono-N-dodecyl ether
Ethylene glycol monolauryl ether
Hydroxyl polyethoxy dodecane
Laureth 9
 
Lauromacrogol
Lauryl ethoxylate
Lauryl monoethoxylate
Macrogol lauryl ether
Oxypolyethoxydodecane
PEG-9 lauryl alcohol
POE-9 lauryl alcohol
Polydocanol
Varithena
13
Nitric Oxideapproved54010102-43-9145068
Synonyms:
(.)NO
(NO)(.)
10102-43-9
14332-28-6
295566_ALDRICH
51005-20-0
51005-21-1
53851-19-7
90452-29-2
AC1L1ADQ
AC1L3QHF
AC1Q6QZ0
AR-1K7463
Bioxyde d'azote
Bioxyde d'azote [French]
C00533
CCRIS 4319
CHEMBL1200689
CHEMBL1234765
CID145068
CID945
D00074
D009569
DB00435
EDRF
EINECS 233-271-0
Endogenous Nitrate Vasodilator
Endothelium-Derived Nitric Oxide
HNO
HSDB 1246
INOmax
INOmax (TN)
Inomax
LS-192158
LS-7547
MolPort-003-929-452
Mononitrogen monoxide
Monoxide, Mononitrogen
Monoxide, Nitrogen
Monoxido de nitrogeno
Monoxyde d'azote
NITRIC-OXIDE
NO
NO(.)
Nitrate Vasodilator, Endogenous
Nitric Oxide, Endothelium Derived
 
Nitric Oxide, Endothelium-Derived
Nitric oxide
Nitric oxide (JAN)
Nitric oxide 10% by volume or more
Nitric oxide trimer
Nitric oxide, compressed [UN1660] [Poison gas]
Nitric oxide, compressed [UN1660] [Poison gas]
Nitrogen monoxide
Nitrogen oxide
Nitrogen oxide (NO)
Nitrogen protoxide
Nitrosyl
Nitrosyl hydride
Nitrosyl hydride ((NO)H)
Nitrosyl radical
Nitroxide radical
Nitroxyl
OHM 11771
Oxide, Nitric
Oxido de nitrogeno(ii)
Oxido nitrico
Oxyde azotique
Oxyde nitrique
Oxyde nitrique [French]
RCRA waste no. P076
Stickmonoxyd
Stickmonoxyd [German]
Stickstoff(II)-oxid
Stickstoff(ii)-oxid
Stickstoffmonoxid
UN 1660
UN1660
UNII-31C4KY9ESH
Vasodilator, Endogenous Nitrate
[NO]
endothelium-derived relaxing factor
monoxido de nitrogeno
monoxyde d'azote
nitric oxide
nitrogen monooxide
nitrogen monoxide
nitrosyl
oxido de nitrogeno(II)
oxido nitrico
oxidonitrogen(.)
oxoazanyl
oxyde azotique
14
Vitamin Capproved, nutraceutical39850-81-75785, 54670067
Synonyms:
(+)-Sodium L-ascorbate
(+)-ascorbate
(+)-ascorbic acid
(2R)-2-[(1S)-1,2-Dihydroxyethyl]-4,5-dihydroxy-furan-3-one
(2R)-2-[(1S)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one
(5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one
129940-97-2
134-03-2 (monosodium salt)
14536-17-5
154170-90-8
2-(1,2-Dihydroxyethyl)-4,5-dihydroxyfuran-3-one
255564_SIAL
259133-78-3
3-Keto-L-gulofuranolactone
3-Oxo-L-gulofuranolactone
3-Oxo-L-gulofuranolactone (enol form)
30208-61-8
33034_RIEDEL
33034_SIAL
47863_SUPELCO
47A605F0-4187-47A8-B0CE-F9E7DA1B0076
50-81-7
50976-75-5
56172-55-5
56533-05-2
57304-74-2
57606-40-3
623158-95-2
6730-29-6
882690-91-7
884381-69-5
885512-24-3
88845-26-5
89924-69-6
95209_FLUKA
95209_SIGMA
95210_FLUKA
95210_SIAL
95212_FLUKA
A0278_SIGMA
A0537
A2174_SIGMA
A2218_SIGMA
A2343_SIGMA
A4403_SIGMA
A4544_SIGMA
A5960_SIGMA
A7506_SIGMA
A92902_ALDRICH
A92902_SIAL
AA
AB00376923
AB1002440
AC1L1L4T
AC1Q77S6
AR-1J3435
Acid Ascorbic
Acide ascorbique
Acide ascorbique [INN-French]
Acido ascorbico
Acido ascorbico [INN-Spanish]
Acidum ascorbicum
Acidum ascorbicum [INN-Latin]
Acidum ascorbinicum
Adenex
Allercorb
Ambap36431-82-0
Antiscorbic Vitamin
Antiscorbic vitamin
Antiscorbutic Vitamin
Antiscorbutic factor
Antiscorbutic vitamin
Arco-Cee
Arco-cee
Ascoltin
Ascoltin (TN)
Ascor-B.I.D.
Ascorb
Ascorbajen
Ascorbate
Ascorbic Acid
Ascorbic Acid, Monosodium Salt
Ascorbic acid
Ascorbic acid (JP15/USP/INN)
Ascorbic acid [BAN:INN:JAN]
Ascorbic acid [INN:BAN:JAN]
Ascorbicab
Ascorbicap
Ascorbicap (TN)
Ascorbicin
Ascorbin
Ascorbinsaeure
Ascorbutina
Ascorbyl radical
Ascorin
Ascorteal
Ascorvit
BPBio1_000363
BSPBio_000329
Babor Baborganic Biological Enzyme Cleanser
C-Level
C-Long
C-Quin
C-Span
C-Vimin
C00072
C6H8O6
CCRIS 57
CE-VI-Sol
CHEBI:29073
CHEMBL196
CID5785
Cantan
Cantaxin
Caswell No. 061B
Catavin C
Ce Lent
Ce lent
Ce-Mi-Lin
Ce-mi-lin
Ce-vi-sol
Cebicure
Cebid
Cebion
Cebione
Cecon
Cee-Caps TD
Cee-Caps Td
Cee-Vite
Cee-caps TD
Cee-vite
Cegiolan
Ceglion
Ceklin
Celaskon
Celin
Cell C
Cemagyl
Cemill
Cenetone
Cenolate
Cereon
Cergona
Cescorbat
Cetamid
Cetane
Cetane-Caps TC
Cetane-Caps TD
Cetane-Caps Tc
Cetane-Caps Td
Cetane-caps TC
Cetane-caps TD
Cetebe
 
Cetemican
Cevalin
Cevatine
Cevex
Cevi-Bid
Cevi-bid
Cevimin
Cevital
Cevitamate
Cevitamic Acid
Cevitamic acid
Cevitamin
Cevitan
Cevitex
Cewin
Chewcee
Ciamin
Cipca
Citriscorb
Citrovit
Colascor
Concemin
Cortalex
D00018
DB00126
Davitamon C
Dora-C-500
Duoscorb
EINECS 200-066-2
FEMA No. 2109
Ferancee
Ferrous ascorbate
HSDB 818
HiCee
Hicee
Hybrin
IDO-C
Ido-C
Iron(II) ascorbate
Iron-ascorbic acid complexes
Juvamine
Kangbingfeng
Kyselina Askorbova
Kyselina askorbova
Kyselina askorbova [Czech]
L(+)-Ascorbate
L(+)-Ascorbic acid
L-(+)-Ascorbate
L-(+)-Ascorbic Acid
L-(+)-Ascorbic acid
L-(+)-ascorbic acid
L-3-Ketothreohexuronic acid lactone
L-3-ketothreohexuronic acid
L-Ascorbate
L-Ascorbic Acid
L-Ascorbic acid
L-Ascorbic acid, free radical form
L-Lyxoascorbate
L-Lyxoascorbic Acid
L-Lyxoascorbic acid
L-Threo-ascorbic acid
L-Threoascorbic acid
L-Xyloascorbate
L-Xyloascorbic Acid
L-Xyloascorbic acid
L-ascorbate
L-threo-Hex-2-enonic acid, gamma-lactone
L-threo-ascorbic acid
L-threo-hex-2-enono-1,4-lactone
LS-145
Laroscorbine
Lemascorb
Liqui-Cee
Liqui-cee
MLS002153776
Magnesium Ascorbicum
Magnorbin
Meri-C
Meri-c
MolPort-001-792-501
Monodehydroascorbic acid
NCGC00091517-01
NCGC00091517-02
NCGC00164357-01
NCI-C54808
NSC 33832
Natrascorb
Natrascorb injectable
Oral Vitamin C
Planavit C
Prestwick3_000325
Proscorbin
Redoxon
Ribena
Ronotec 100
Rontex 100
Roscorbic
Rovimix C
SMR001233160
Scorbacid
Scorbu C
Scorbu-C
Secorbate
Semidehydroascorbate
Sodascorbate
Sodium Ascorbate (Ascorbic Acid)
Stuartinic
Suncoat VC 40
Sunkist
Testascorbic
Tolfrinic
UNII-PQ6CK8PD0R
VASC
Vicelat
Vicin
Vicomin C
Viforcit
Viscorin
Viscorin 100M
Vitace
Vitacee
Vitacimin
Vitacin
Vitamin C
Vitamin- C
Vitamin-?C
Vitamisin
Vitascorbol
W210901_ALDRICH
Xitix
antiscorbic vita min
ascor-b.i.d
ascorbate
ascorbic acid
bmse000182
cee-caps td
cevibid
component of Cortalex
component of E and C-Level
component of Endoglobin Forte
component of Ferancee
e 300
e-300
e300
gamma-Lactone L-threo-Hex-2-enonate
gamma-Lactone L-threo-Hex-2-enonic acid
l-ascorbic acid
l-threo-hex-1-eofuranos-3-ulose
nchembio.174-comp5
nchembio.89-comp1
nchembio.92-comp2
nchembio821-comp9
roscorbi c
vitamin C
15
Vitamin Eapproved, nutraceutical35059-02-914985
Synonyms:
(+)-a-Tocopherol
(+)-alpha-Tocopherol
(+)-alpha-tocopherol
(+)-α-tocopherol
(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-ol
(2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
(2R,4'R,8'R)-a-Tocopherol
(2R,4'R,8'R)-alpha-Tocopherol
(2R,4'R,8'r)-alpha-tocopherol
(R,R,R)-a-Tocopherol
(R,R,R)-alpha-Tocopherol
(R,R,R)-alpha-tocopherol
(R,R,R)-α-tocopherol
5,7,8-Trimethyltocol
Amino-Opti-E
Aquasol E
D-alpha-Tocopherol
Daltose
Denamone
E-200 I.U. Softgels
 
E-Complex-600
E-Ferol
E-Vitamin succinate
Eprolin
Gordo-Vite E
Phytogermin
Phytogermine
RRR-alpha-tocopherol
RRR-alpha-tocopheryl
Tocopherol
Vitamin E
Vitamin Ea
Vitamin Plus E Softgells
Vitamin e
Vitec
a-D-Tocopherol
a-Tocopherol
alpha-Tocopherol
alpha-delta-Tocopherol
d-alpha-tocopherol
d-α-tocopherol
delta-alpha-Tocopherol
16Tocotrienols352
17Tocopherols355
18CalamusNutraceutical312
19TocotrienolNutraceutical352
20TocopherolNutraceutical355

Interventional clinical trials:

(show top 50)    (show all 60)
idNameStatusNCT IDPhase
1Patent Foramen Ovale in Cryptogenic Stroke StudyCompletedNCT00697151Phase 4
2Long-term Safety Study of the GORE® HELEX® Septal OccluderCompletedNCT00581308Phase 4
3Device Closure Versus Medical Therapy for Cryptogenic Stroke Patients With High-Risk Patent Foramen Ovale (DEFENSE-PFO)RecruitingNCT01550588Phase 4
4PC-Trial: Patent Foramen Ovale and Cryptogenic EmbolismActive, not recruitingNCT00166257Phase 4
5Atrial Fibrillation Ablation Compared to Rate Control Strategy in Patients With Impaired Left Ventricular FunctionNot yet recruitingNCT02509754Phase 4
6Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) StudyCompletedNCT00431834Phase 3
7Medtronic Concomitant Utilization of Radio Frequency for Atrial Fibrillation CURE-AF/PersistentCompletedNCT00506493Phase 3
8Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke RecurrenceActive, not recruitingNCT00562289Phase 3
9Evaluation of the STARFlex® Septal Closure System in Patients With a Stroke or TIA Due to the Possible Passage of a Clot of Unknown Origin Through a Patent Foramen Ovale (PFO)Active, not recruitingNCT00201461Phase 2, Phase 3
10GORE® HELEX® Septal Occluder / GORE® Septal Occluder for Patent Foramen Ovale (PFO) Closure in Stroke Patients - The Gore REDUCE Clinical StudyActive, not recruitingNCT00738894Phase 3
11MIST II PFO-Migraine Trial With BioSTAR® Bioabsorbable Septal Repair ImplantActive, not recruitingNCT00283738Phase 2, Phase 3
12The Coherex FlatStent™ EF PFO Migraine RegistryNot yet recruitingNCT01280578Phase 3
13Right to Left Cardiac Shunt DetectionTerminatedNCT01773252Phase 3
14Cardiox Shunt Detection Technology StudyTerminatedNCT01333761Phase 3
15ESCAPE Migraine TrialTerminatedNCT00267371Phase 3
16Premium Migraine TrialCompletedNCT00355056Phase 2
17Safety Study of Varisolve® Procedure for Treatment of Varicose Veins in Patients With Right-to-left Cardiac ShuntCompletedNCT00442364Phase 2
18Patients With Patent Foramen Ovale and Endocardial Device Leads on Apixaban for Prevention of Paradoxical EmboliRecruitingNCT02378623Phase 2
19RESPECT PFO Clinical TrialActive, not recruitingNCT00465270Phase 2
20PRIMA PFO Migraine TrialTerminatedNCT00505570Phase 2
21Catheter Thrombectomy in Patients With Massive Pulmonary EmbolismTerminatedNCT00314002Phase 1, Phase 2
22Effectiveness and Safety of Transcatheter Patent Foramen Ovale Closure for MigraineCompletedNCT02127294
23Comorbidities Associated With Migraine and Patent Foramen Ovale (CAMP)CompletedNCT01257880
24Procedural Success and Safety of the Nit-Occlud® Patent Foramen Ovale (PFO) Closure Device and Its Application SystemCompletedNCT00968032
25Nitrogen Bubble Detection After Simulated Dives in Divers With PFO and After PFO ClosureCompletedNCT01854281
26Risk of Stroke in Pulmonary Embolism With a Patent Foramen Ovale (PFO)CompletedNCT00831259
27Safety and Effectiveness Study of the Solysafe Septal Occluder in Patients With Atrial Septum Defect and Patent Foramen OvaleCompletedNCT00207376
28Impact Of Closure Of Patent Foramen Ovale On Apnoea-Hypopnoea-Index, Nocturnal Hypoxemia And Systemic Vascular Function In Patients With Obstructive Sleep ApnoeaCompletedNCT01780207
29Patent Foramen Ovale in Children With Migraine HeadachesCompletedNCT00750594
30The Paradigm II Trial: PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression IllnessCompletedNCT00196040
31GORE® Septal Occluder European Union Clinical EvaluationCompletedNCT01605851
32Identification the Cause of Silent Cerebral infarctiON in Healthy Subjects (ICONS)CompletedNCT01429948
33Surgical Tourniquets and Cerebral EmboliCompletedNCT02240732
34Hip Fracture and Patent Foramen OvaleRecruitingNCT02564133
35Patent Foramen Ovale and the Risk of Postoperative Delirium Following Elective Hip and Knee Arthroplasty SurgeriesRecruitingNCT02400892
36Pulmonary Embolism and Stroke in Patient With Patent Foramen OvaleRecruitingNCT01216423
37Decompression Sickness in Divers With or Without Patent Foramen OvaleRecruitingNCT02432131
38Prospective Clinical Follow-up After the Percutaneous Closure of a Patent Foramen OvaleRecruitingNCT01149447
39Timing of Closure of Patent Foramen Ovale Following BirthRecruitingNCT01032785
40InterSEPT: In‐Tunnel SeptRx European PFO TrialRecruitingNCT01385670
41Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and OutcomeRecruitingNCT01934725
42International PFO ConsortiumRecruitingNCT00859885
43Occluder Size Determination in Transcatheter ASD II Closure Based on 3D TEE AssessmentRecruitingNCT02601768
44FIH Study With CBSORecruitingNCT01960491
45Correlation of Right-left Shunt Detection in Cardioembolism Etiology in Stroke Patient.RecruitingNCT02351076
46Clinical Proteomic Research for the BrainRecruitingNCT00983723
47Observatory of Pulmonary Arterial Hypertension of Congenital Heart DiseaseRecruitingNCT02260362
48Infant Nasal Nitric Oxide Levels in Congenital Heart DiseaseRecruitingNCT02551107
49Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD PatientsRecruitingNCT02537769
50Lifetech CeraFlex™ Post-Market Surveillance StudyActive, not recruitingNCT02621528

Search NIH Clinical Center for Patent Foramen Ovale


Cochrane evidence based reviews: Foramen Ovale, Patent

Genetic Tests for Patent Foramen Ovale

About this section

Anatomical Context for Patent Foramen Ovale

About this section

MalaCards organs/tissues related to Patent Foramen Ovale:

33
Brain, Heart, Liver, Spinal cord, Lung, Endothelial, Testes

Animal Models for Patent Foramen Ovale or affiliated genes

About this section

MGI Mouse Phenotypes related to Patent Foramen Ovale:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053699.3ACTC1, EDNRA, GATA4, GATA6, MYH6, NKX2-5
2MP:00053909.0CITED2, EDNRA, F2, FGA, GATA4, MTHFR
3MP:00028738.9ACTC1, CITED2, EDNRA, F12, F2, GATA4
4MP:00053888.9CITED2, EDNRA, F13A1, F2, GATA4, GATA6
5MP:00053808.4CITED2, EDNRA, F2, F5, FGA, GATA4
6MP:00053978.2CITED2, CLNK, EDNRA, F13A1, F2, FGA
7MP:00036318.0CITED2, EDNRA, F12, F2, F5, FGA
8MP:00053857.3ACTC1, CITED2, EDNRA, F13A1, F2, F5
9MP:00107686.8ACTC1, APOH, CITED2, EDNRA, F13A1, F2
10MP:00053766.1ACTC1, APOH, CITED2, EDNRA, F12, F13A1

Publications for Patent Foramen Ovale

About this section

Articles related to Patent Foramen Ovale:

(show top 50)    (show all 642)
idTitleAuthorsYear
1
A rare case of cryptogenic stroke with an incidental finding of patent foramen ovale. (25876305)
2015
2
Post-Operative Multiple Thrombosis Associated with Patent Foramen Ovale: Embolic Stroke, Right Atrial Thrombi, Pulmonary Embolism and Deep Vein Thrombosis. (26448826)
2015
3
A meta-analysis of case-control studies of the association of migraine and patent foramen ovale. (26527111)
2015
4
Role of occlusive devices to prevent thromboembolism among persons with a patent foramen ovale and prior stroke. (25744863)
2015
5
Patent foramen ovale and gut ischemia in potential intestinal transplant recipients. (25221903)
2014
6
Decline in mean platelet volume in patients with patent foramen ovale undergoing percutaneous closure. (25192299)
2014
7
Is closure of patent foramen ovale to prevent ischaemic stroke ever justified? (24167203)
2013
8
Neonatal systemic thromboembolism secondary to ductus arteriosus aneurysm and patent foramen ovale. (21801317)
2013
9
Determination of the Optimum Number of Cardiac Cycles to Differentiate Intra-Pulmonary Shunt and Patent Foramen Ovale by Saline Contrast Two- and Three-Dimensional Echocardiography. (24028319)
2013
10
Current evidence for closure of a patent foramen ovale for cryptogenic stroke prevention. (24373020)
2013
11
Thrombus formation in a patent foramen ovale. (23528287)
2013
12
Death by patent foramen ovale in a soccer player. (23468450)
2013
13
Patent foramen ovale in severe obstructive sleep apnea: clinical features and effects of closure. (22924163)
2013
14
Neuroimaging findings in cryptogenic stroke patients with and without patent foramen ovale. (23339957)
2013
15
Patent Foramen Ovale and Migraine Attacks: A Systematic Review. (24355354)
2013
16
Management of the stroke patient with patent foramen ovale: new insights and persistent questions in the wake of recent randomized trials. (23715857)
2013
17
Neurosurgery in the Semisitting Position in Patients with a Patent Foramen Ovale. (23920299)
2013
18
A systematic review of closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and cryptogenic stroke or transient ischemic attack. (24300230)
2013
19
Follow-up to 'Cholecystectomy in the presence of a large patent foramen ovale: laparoscopic or open?'. (23541851)
2013
20
Patent foramen ovale and atrial septal aneurysm can cause ischemic stroke in patients with antiphospholipid syndrome. (22836909)
2013
21
Updating the evidence on patent foramen ovale closure versus medical therapy in patients with cryptogenic stroke: aa8^systematic review and comprehensive meta-analysis of 2,303 patients from three randomised trials and 2,231 patients from 11 observational studies. (24240356)
2013
22
Platypnoea-orthodeoxia in an elderly man with patent foramen ovale and dilated ascending aorta. (22089080)
2012
23
Platypnea-orthodeoxia syndrome related to right hemidiaphragmatic elevation and a 'stretched' patent foramen ovale. (23230257)
2012
24
Patent foramen ovale, dialysis and microembolization. (22487266)
2012
25
Secondary stroke prevention: patent foramen ovale, aortic plaque, and carotid stenosis. (22422912)
2012
26
Simultaneous myocardial infarction and ischaemic stroke secondary to paradoxical emboli through a patent foramen ovale. (22930890)
2012
27
Stress-induced cardiomyopathy after patent foramen ovale closure: what role did anesthesia play? (22633744)
2012
28
Prevalence of patent foramen ovale with right-to-left shunting in dogs with pulmonic stenosis. (22151278)
2012
29
Focal neurological deficit with tricuspid endocarditis and patent foramen ovale. (22878350)
2012
30
Transcranial Doppler quantification of residual shunt after percutaneous patent foramen ovale closure: correlation of device efficacy with intracardiac anatomic measures. (22364421)
2012
31
Can patent foramen ovale affect rehabilitation? The uncommon association of platypnea-orthodeoxia syndrome and stroke. (21468677)
2011
32
Electrocardiographic changes and arrhythmias following percutaneous atrial septal defect and patent foramen ovale device closure. (21563292)
2011
33
Evaluation of patent foramen ovale in young adults with cryptogenic stroke. (22577450)
2011
34
Transthoracic echocardiography guidance during percutaneous closure of patent foramen ovale. (21967656)
2011
35
Contrast transoesophageal echocardiography remains superior to contrast-enhanced cardiac magnetic resonance imaging for the diagnosis of patent foramen ovale. (21193485)
2011
36
Role of patent foramen ovale in migraine etiology and treatment: a review. (21827543)
2011
37
Explantation of patent foramen ovale closure devices: a multicenter survey. (21596333)
2011
38
Usefulness of intravenously administered fluid replenishment for detection of patent foramen ovale by transesophageal echocardiography. (20854974)
2010
39
Late cardiac perforation after transcatheter closure of patent foramen ovale mimicking acute type a aortic dissection. (20417804)
2010
40
The association of patent foramen ovale transcatheter closure and psychological well-being. (20089005)
2010
41
Patent foramen ovale among patients with mild chronic obstructive pulmonary disease and unexplained hypoxia. (20345439)
2010
42
Acute myocardial infarction involving two coronary arteries due to a patent foramen ovale. (20676784)
2010
43
Patent foramen ovale and obstructive sleep apnea: a new association? (20451427)
2010
44
A case of platypnea-orthodeoxia syndrome caused by the interaction between the presence of corrected transposition of the great arteries and patent foramen ovale. (18706706)
2010
45
Paradoxical emboli--clinical importance of transcranial Doppler for detection of patent foramen ovale. (21443152)
2010
46
A third treatment option for entrapped thrombus in patent foramen ovale. (20548835)
2010
47
Lack of association between migraine headache and patent foramen ovale: results of a case-control study. (20231534)
2010
48
No indication for patent foramen ovale closure in migraine. (19949472)
2009
49
Do common prothrombotic mutations influence the risk of cerebral ischaemia in patients with patent foramen ovale? Systematic review and meta-analysis. (19404532)
2009
50
That balloon atrial septostomy is associated with preoperative stroke in neonates with transposition of the great arteries is another powerful argument in favor of therapeutic closure of every patent foramen ovale. (16828611)
2006

Variations for Patent Foramen Ovale

About this section

Expression for genes affiliated with Patent Foramen Ovale

About this section
Search GEO for disease gene expression data for Patent Foramen Ovale.

Pathways for genes affiliated with Patent Foramen Ovale

About this section

GO Terms for genes affiliated with Patent Foramen Ovale

About this section

Cellular components related to Patent Foramen Ovale according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1platelet alpha granuleGO:003109110.5F5, FGA
2platelet alpha granule lumenGO:003109310.1F13A1, F5, FGA
3blood microparticleGO:00725629.7ACTC1, F13A1, F2, FGA, SERPINC1
4extracellular spaceGO:00056158.9ACTC1, APOH, F12, F2, F5, FGA

Biological processes related to Patent Foramen Ovale according to GeneCards Suite gene sharing:

(show top 50)    (show all 54)
idNameGO IDScoreTop Affiliating Genes
1cardiac ventricle morphogenesisGO:000320810.9GATA4, NKX2-5
2cellular response to gonadotropin stimulusGO:007137110.9GATA4, GATA6
3regulation of cardiac muscle cell proliferationGO:006004310.9GATA4, NKX2-5
4embryonic heart tube left/right pattern formationGO:006097110.9CITED2, NKX2-5
5bundle of His developmentGO:000316610.8NKX2-5, TBX5
6ventricular cardiac muscle tissue developmentGO:000322910.8GATA4, TBX5
7cardiac right ventricle morphogenesisGO:000321510.8GATA4, TBX20
8Clara cell differentiationGO:006048610.8GATA6, NKX2-1
9tube morphogenesisGO:003523910.7GATA4, GATA6
10cardiac muscle hypertrophy in response to stressGO:001489810.7GATA4, GATA6
11lung saccule developmentGO:006043010.7GATA6, NKX2-1
12heart contractionGO:006004710.7ACTC1, NKX2-5
13Type II pneumocyte differentiationGO:006051010.7GATA6, NKX2-1
14intestinal epithelial cell differentiationGO:006057510.7GATA4, GATA6
15adult heart developmentGO:000751210.7MYH6, NKX2-5
16cardiac muscle tissue developmentGO:004873810.7GATA4, GATA6, NKX2-5
17negative regulation of fibrinolysisGO:005191810.6APOH, F2
18embryonic heart tube developmentGO:003505010.6GATA4, NKX2-5, TBX20
19outflow tract septum morphogenesisGO:000314810.6GATA6, NKX2-5, TBX20
20transdifferentiationGO:006029010.6GATA4, TBX5
21cardiac septum developmentGO:000327910.6GATA4, TBX20
22cardiac muscle tissue morphogenesisGO:005500810.6ACTC1, NKX2-5, TBX20
23canonical Wnt signaling pathwayGO:006007010.6GATA4, MYH6, NKX2-5
24blood coagulation, intrinsic pathwayGO:000759710.4APOH, F12, F2
25positive regulation of cardioblast differentiationGO:005189110.4GATA4, GATA6, NKX2-5, TBX5
26endocardial cushion developmentGO:000319710.4CITED2, GATA4, TBX5
27BMP signaling pathwayGO:003050910.4GATA4, MYH6, NKX2-5
28positive regulation of cardiac muscle cell proliferationGO:006004510.4GATA4, GATA6, TBX20, TBX5
29fibrinolysisGO:004273010.4F12, F2, FGA
30ventricular septum developmentGO:000328110.4CITED2, GATA4, TBX5
31heart loopingGO:000194710.4CITED2, GATA4, NKX2-5, TBX20
32outflow tract morphogenesisGO:000315110.4CITED2, NKX2-5, TBX20
33response to estrogenGO:004362710.3CITED2, GATA4, GATA6
34blood circulationGO:000801510.3F5, MTHFR, TBX20
35cardiac muscle cell differentiationGO:005500710.3GATA4, GATA6, NKX2-5, TBX5
36positive regulation of blood coagulationGO:003019410.3APOH, F12, F2
37regulation of blood coagulationGO:003019310.3APOH, F12, F2
38plasminogen activationGO:003163910.3APOH, FGA
39negative regulation of cell migrationGO:003033610.2CITED2, NKX2-1, TBX5
40atrial septum morphogenesisGO:006041310.2GATA4, NKX2-5, TBX20, TBX5
41platelet degranulationGO:000257610.2F13A1, F5, FGA
42in utero embryonic developmentGO:000170110.0CITED2, EDNRA, GATA4, GATA6, MYH6
43cardiac muscle contractionGO:00600489.9ACTC1, MYH6, NKX2-5
44negative regulation of transcription, DNA-templatedGO:00458929.9CITED2, GATA6, NKX2-1, NKX2-5, TBX20
45heart developmentGO:00075079.8CITED2, EDNRA, GATA4, NKX2-5, TBX5
46male gonad developmentGO:00085849.7CITED2, GATA4, GATA6
47positive regulation of transcription, DNA-templatedGO:00458939.5CITED2, GATA4, GATA6, NKX2-1, NKX2-5, TBX20
48platelet activationGO:00301689.5F13A1, F2, F5, FGA
49positive regulation of transcription from RNA polymerase II promoterGO:00459449.1CITED2, GATA4, GATA6, NKX2-1, NKX2-5, TBX20
50blood coagulationGO:00075968.5APOH, F12, F13A1, F2, F5, FGA

Molecular functions related to Patent Foramen Ovale according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1RNA polymerase II transcription factor bindingGO:000108510.5GATA4, GATA6, TBX20
2transcription factor activity, RNA polymerase II distal enhancer sequence-specific bindingGO:000370510.2GATA4, GATA6, NKX2-1, NKX2-5
3transcription regulatory region DNA bindingGO:004421210.0GATA4, GATA6, NKX2-1, NKX2-5
4transcription factor bindingGO:00081349.8GATA4, GATA6, NKX2-5, TBX5
5transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific bindingGO:00012289.5GATA4, GATA6, NKX2-5, TBX5
6RNA polymerase II regulatory region sequence-specific DNA bindingGO:00009779.3GATA4, GATA6, NKX2-1, TBX20, TBX5
7transcription factor activity, sequence-specific DNA bindingGO:00037009.1CITED2, GATA4, GATA6, NKX2-1, NKX2-5, TBX20

Sources for Patent Foramen Ovale

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet